Wikidata entity: Q64139898
Quantities
| P2899 | minimum age | 18 |
| P1132 | number of participants | 1600 |
| P6099 | clinical trial phase | ... | Q42824440 (phase II clinical trial) | phase II clinical trial |
| P6099 | clinical trial phase | ... | Q42824827 (phase III clinical trial) | phase III clinical trial |
| P17 | country | ... | Q30 (United States) | United States |
| P582 | end time | ... | 2019-11-20 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P6153 | research site | ... | Q30269657 (Coastal Carolina Research Center) | Coastal Carolina Research Center |
| P6153 | research site | ... | Q30269674 (Collaborative Neuroscience Network) | Collaborative Neuroscience Network |
| P6153 | research site | ... | Q30269699 (Clinical Research Associates) | Clinical Research Associates |
| P6153 | research site | ... | Q30269704 (Meridien Research) | Meridien Research |
| P6153 | research site | ... | Q30269801 (Dynamed Clinical Research) | Dynamed Clinical Research |
| P6153 | research site | ... | Q30269845 (Diablo Clinical Research) | Diablo Clinical Research |
| P6153 | research site | ... | Q30270033 (PMG Research) | PMG Research |
| P6153 | research site | ... | Q30270309 (Premiere Research Institute) | Premiere Research Institute |
| P6153 | research site | ... | Q30270449 (Sundance Clinical Research) | Sundance Clinical Research |
| P6153 | research site | ... | Q50035554 (Pharmacology Research Institute) | Pharmacology Research Institute |
| P6153 | research site | ... | Q50039766 (Regeneris Medical) | Regeneris Medical |
| P580 | start time | ... | 2019-03-25 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | BHV3500-201: Phase II: Double-Blind, Randomized, Placebo Controlled, Dose-Ranging Trial of BHV-3500 for the Acute Treatment of Migraine | ??? |
| P3098 | ClinicalTrials.gov ID | NCT03872453 |
Why not click here or view trends?
log id: 4248847